Tongling Nonferrous Metals Group (000630.SZ) won the exploration and mining rights for the Jiguan Mountain-Hucun Copper Gold Molybdenum Mine for 3.204 billion yuan.
Tongling Nonferrous Metals Group Co., Ltd. (000630.SZ) released an announcement on November 4, 2025, that the company has completed a transaction with a value of 3.204 billion yuan...
Tongling Nonferrous Metals Group (000630.SZ) announced on November 4, 2025, that the company won the exploration and mining rights of the Jiguan Mountain-Hucun Copper, Gold, and Molybdenum Mine for 3.204 billion yuan, and jointly signed the "Confirmation of Exploration Rights Transfer Transaction" with the Anhui Province Real Estate Registration Center (Anhui Province Land and Resources Reserve Development Center).
The exploration and mining rights of the Jiguan Mountain-Hucun Copper, Gold, and Molybdenum Mine are located near the Dongguashan Copper Mine in Tongling City, Anhui Province. Winning these exploration rights aligns with the company's development strategy focusing on the copper industry as its main responsibility and main business. It is beneficial for increasing the company's reserves of non-ferrous metal resources, further enhancing its sustainable development capabilities, and promoting the company's growth, strength, and optimization.
Related Articles

Hangzhou Huning Elevator Parts (300669.SZ) plans to inject 40 million yuan into Hongjian Optoelectronics to advance strategic transformation and upgrading.

Wang Shan Wang Shui-B (02630) has a sale price of HK$33.37 per share. The Hong Kong public offering has been oversubscribed 6238.42 times.

US Stock Market Move | Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA.US) surged nearly 13% in pre-market trading, with Q3 revenue and adjusted earnings per share both exceeding expectations.
Hangzhou Huning Elevator Parts (300669.SZ) plans to inject 40 million yuan into Hongjian Optoelectronics to advance strategic transformation and upgrading.

Wang Shan Wang Shui-B (02630) has a sale price of HK$33.37 per share. The Hong Kong public offering has been oversubscribed 6238.42 times.

US Stock Market Move | Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA.US) surged nearly 13% in pre-market trading, with Q3 revenue and adjusted earnings per share both exceeding expectations.

RECOMMEND

Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
05/11/2025

Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
05/11/2025

Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
05/11/2025


